RADX Form 6-K details final director interest notices to ASX
Filing Impact
Filing Sentiment
Form Type
6-K
Rhea-AI Filing Summary
Radiopharm Theranostics Limited (RADX) submitted a Form 6-K to make U.S. investors aware of two announcements it released to the Australian Securities Exchange on November 25, 2025. The announcements are titled “Final Director’s Interest Notice - LA” and “Final Director’s Interest Notice - PH,” which typically relate to the final disclosure of a director’s holdings or changes in interests. Copies of these notices are attached to the Form 6-K as exhibits, but the information is furnished rather than filed, meaning it is not automatically incorporated into other U.S. securities law filings unless specifically referenced.
Positive
- None.
Negative
- None.
FAQ
What did Radiopharm Theranostics Limited (RADX) report in this Form 6-K?
Radiopharm Theranostics Limited reported that it released two announcements to the Australian Securities Exchange titled “Final Director’s Interest Notice - LA” and “Final Director’s Interest Notice - PH,” and attached them as exhibits.
Which exhibits are included with Radiopharm Theranostics Limited’s Form 6-K?
The Form 6-K includes Exhibit 99.1, titled “Final Director’s Interest Notice - LA,” and Exhibit 99.2, titled “Final Director’s Interest Notice - PH.”
Are the attached director interest notices considered filed under U.S. securities laws for RADX?
The company states that this Form 6-K, including the attached notices, is furnished rather than filed and will not be incorporated into other U.S. securities filings unless specifically referenced.
Why did Radiopharm Theranostics (RADX) issue these final director’s interest notices?
The Form 6-K only notes that the company published “Final Director’s Interest Notice - LA” and “Final Director’s Interest Notice - PH” on the Australian Securities Exchange; detailed reasons would be contained in the attached notices themselves.
Does this Form 6-K for RADX disclose any financial results or major transactions?
No, this Form 6-K is administrative in nature and focuses on furnishing director interest notices rather than financial results or major corporate transactions.